Quick search:
Content Search
Result Content Research
Result Content Research
1 Why Atea Pharmaceuticals Is Imploding Today
2 What’s Next For Ionis Pharmaceuticals Stock After A 14% Fall?
3 FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH
4 Island Pharmaceuticals to discuss its potential dengue fever preventative at Pharma Meeting Brazil & Latam 2021
5 If You Invested $5,000 in Vertex Pharmaceuticals In 2016, This Is How Much You Would Have Today
6 Companion Animal Pharmaceuticals Market: Rising prevalence of zoonotic illnesses to drive the market
7 Kala Pharmaceuticals Announces Appointment of C. Daniel Myers to Board of Directors
8 CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease
9 Adamis Pharmaceuticals stock rockets on heavy volume after opioid overdose treatment gets FDA approval
10 Pharmaceutical company recalls blood pressure medications over possible cancer-causing impurity
11 Rhythm Pharmaceuticals to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021
12 MyMD Pharmaceuticals to Discuss its Novel Therapies for Aging and Related Diseases at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21
13 OliX Pharmaceuticals Enters Agreement with Pharmaron to Advance Non-clinical Toxicology Testing for Hepatitis B Candidate OLX703A
14 Vivera Pharmaceuticals Co-Founder Nominated for Inspirational Women Awards
15 China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection
16 CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021
17 Hanover County hosting Prescription Drug Take-Back Day to collect unwanted pharmaceuticals from residents
18 OPDP Sends Third Untitled Letter of the Year to Eton Pharmaceuticals
19 Zynerba Pharmaceuticals Announces Presentation of Poster at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit
20 Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity
21 Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
22 Tonix Pharmaceuticals Opens Infectious Disease R&D Center in Maryland
23 Johnson & Johnson’s net profit up 3.2% on strong pharmaceuticals business
24 Kala Pharmaceuticals Shares Down 17% After Rajeev Shah of RA Capital Leaves Board
25 Petros Pharmaceuticals Announces Closing of $5.7 Million Registered Direct Offering
26 BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Smal
27 Voyageur Pharmaceuticals Ltd., Announces The Completion of a New Scientific Advisory Board With World Class Leading Physicians
28 NRx Pharmaceuticals Announces Progress on Worldwide Commercial Scale Development of ZYESAMI™ (aviptadil)
29 Worldwide Oncology Pharmaceuticals Industry to 2026
30 Roche expects higher 2021 sales as Delta spurs COVID-19 tests
31 COUR Pharmaceuticals Announces First in Human Dosing in Proof-of-Concept Trial of CNP-201 to Treat Peanut Allergy
32 Gates Foundation to spend $120 mln to speed access to generics of Merck COVID-19 pill
33 Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today
34 What's Next For Ionis Pharmaceuticals Stock After A 14% Fall?
35 Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains
36 Investing in Reata Pharmaceuticals (NASDAQ:RETA) five years ago would have delivered you a 291% gain
37 Inequitable Conduct And The Duty To Disclose, Belcher Pharmaceuticals, LLC v. Hospira, Inc.
38 Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Value Stock
39 Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
40 House passes Guthrie's Pharmaceutical Manufacturing Bill
41 Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer
42 CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement
43 Alnylam Pharmaceuticals, Inc. (ALNY) Fell Out Of Favor With Hedge Funds?
44 Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
45 Catalyst Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains
46 INVESTOR ALERT: SPECTRUM PHARMACEUTICALS, INC. (NASDAQ:SPPI) INVESTOR LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spe
47 Global Pharmaceutical Contract Development and Manufacturing Markets, 2021-2026
48 Thinking about buying stock in Progenity, Atea Pharmaceuticals, Peabody Energy, Adamis Pharmaceuticals, or Ion Geophysical?
49 Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund
50 EXCLUSIVE WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document
51 Here's What Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Structure Looks Like
52 Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology
53 Pharmaceutical Companies Pay Over $400 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drugs
54 Sen. Paul pushing bill that would remove animal testing mandate for pharmaceuticals
55 Enanta Pharmaceuticals Presents New Data for EDP-235, its Lead Oral Protease Inhibitor Designed for the Treatment of COVID-19, at the ISIRV–WHO Virtual Conference 2021
56 Is Apellis Pharmaceuticals, Inc. (APLS) Going to Burn These Hedge Funds?
57 Global Pharmaceutical Manufacturing Market Trends & Analysis 2021-2028 by Molecule Type, Drug Development Type, Formulation, Routes of Administration, Sales Channel, Age Group
58 Theseus Pharmaceuticals Gained in First Day. Life Time Group Fell.
59 Marinus Pharmaceuticals Provides Strategic Update at Virtual R&D Event
60 Global Continuous Manufacturing Market in Pharmaceuticals & Biopharmaceuticals to 2027
61 CytoReason and Summit Pharmaceuticals International Announce the Introduction of an AI Platform to One of Japan's Top Pharmaceutical Companies
62 Exclusive: US Foods & Pharmaceuticals plans to call Minot home, bring dairy farm business
63 Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Infectious Disease R&D Center in Maryland
64 Insights on the $177.4 Billion Oncology Pharmaceuticals Global Market to 2026
65 Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
66 Why Atea Pharmaceuticals Is Up 17% Today
67 COVID-19 and Pharmaceuticals: International & nation..collaborations will increase Indias business prospects
68 September Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
69 Why Xenon Pharmaceuticals Stock Is Screaming Higher Today
70 Teva halts output at U.S. drug plant after FDA flags concerns
71 Currax Pharmaceuticals celebrates headquarters relocation to Brentwood | Business |
72 Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma
73 10 Pharmaceutical Stocks to Buy According to Lawrence Hawkins’ Prosight Capital
74 COVID-19 pill developers aim to top Merck, Pfizer efforts
75 NRx Pharmaceuticals Announces Second Favorable Safety Report for ZYESAMI™ (aviptadil) in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19
76 Global Pharmaceutical Manufacturing Market Report 2021-2028
77 Revision of the EU general pharmaceuticals legislation – public consultation is now open
78 Overdose Unknown: How Anebulo Pharmaceuticals Is Working to Solve a Growing Marijuana Overdose Problem
79 Fact-checking Bernie Sanders on pharmaceutical lobbying pushback
80 Marinus Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Ganaxolone in CDKL5 Deficiency Disorder
81 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2021: COVID-19 Growth And Change To 2030
82 Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19
83 Catalyst Pharmaceuticals Receives Positive Decision from Appeals Court That Supports Orphan Drug Exclusivity for Firdapse® for
84 US Pharmaceutical Logistics Industry Assessment 2021-2026 with Profiles of DHL, FedEx, UPS, XPO Logistics, and More
85 InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update
86 Merck says research shows its COVID-19 pill works against variants
87 MyMD Pharmaceuticals Announces New Data Demonstrating 8000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD
88 India Active Pharmaceutical Ingredients (API) Markets, Competition, Forecast & Opportunities, FY2027 by Method of Synthesis, Source, Therapeutic Application, & Drug Type
89 NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMI (aviptadil)
90 D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China
91 $300 million financing for Centessa Pharmaceuticals
92 Corvus Pharmaceuticals Rise Again, Following Friday's Doubling
93 Sun Pharmaceuticals basks in firm US sales
94 Corvus Pharmaceuticals Provides Updates on Mupadolimab (Anti-CD73) Programs in Oncology and Infectious Disease
95 Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
96 America’s Pharmaceutical Supply Chain: An Overview of the Policy Landscape and Potential Path Forward
97 Molnupiravir, a drug developed by Merck, could be the first oral antiviral medicine for covid-19
98 Centessa Pharmaceuticals Announces $300 Million Financing
99 Western Pa. business expanding, creating nearly 700 new, full-time jobs
100 Worldwide Orphan Drugs Industry to 2027